Recruit through 2023 first implant 1st of January 2024, have good enough results during the year for breakthrough status then start selling 2025 (cant imagine it happening due to this being a biotech).
Getting paid 10 million for a trial isn't bad going though looks like another raise is inevitable unless the IPO comes first.
$66.32 price target - Evolution Capital initiation of coverage, page-5
-
- There are more pages in this discussion • 104 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.93 |
Change
-0.290(2.37%) |
Mkt cap ! $252.1M | |||
| Open | High | Low | Value | Volume |
| $12.20 | $12.22 | $11.21 | $199.1K | 17.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 577 | $11.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.93 | 131 | 1 |
View Market Depth
| Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |